Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
759.88
630.96
513.08
465.93
427.60
328.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
759.88
630.96
513.08
465.93
427.60
328.85
Raw Material Cost
493.38
386.59
340.71
307.56
270.74
224.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-21.52
9.59
-15.27
-4.74
3.67
-12.75
Employee Cost
122.92
87.46
70.32
63.41
58.32
43.57
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
70.99
69.15
57.09
47.27
40.18
32.22
Total Expenditure (Excl Depreciation)
665.77
552.79
452.86
413.50
372.91
287.39
Operating Profit (PBDIT) excl Other Income
94.11
78.17
60.22
52.43
54.69
41.46
Other Income
18.02
13.47
9.97
6.71
3.09
2.49
Operating Profit (PBDIT)
112.13
91.64
70.19
59.14
57.78
43.95
Interest
4.38
1.11
0.79
1.42
1.29
2.53
Exceptional Items
0.00
0.00
0.00
0.00
-21.62
0.00
Gross Profit (PBDT)
107.75
90.53
69.40
57.72
34.87
41.42
Depreciation
27.99
13.44
12.36
12.15
12.97
9.29
Profit Before Tax
79.76
77.09
57.04
45.57
21.91
32.14
Tax
18.76
18.90
14.41
7.48
6.17
8.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
60.99
58.19
42.63
38.09
15.74
23.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
60.99
58.19
42.63
38.09
15.74
23.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
-0.17
-7.47
Minority Interest
0.00
0.00
0.00
0.00
0.26
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
60.99
58.19
42.63
38.09
15.83
16.21
Equity Capital
10.48
10.40
10.46
10.90
6.41
6.41
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
495.29
439.54
391.81
383.88
192.71
0.00
Earnings per share (EPS)
29.1
27.98
20.38
17.47
8.7
8.9
Diluted Earnings per share
28.87
27.88
19.7
18.58
8.7
8.9
Operating Profit Margin (Excl OI)
12.38%
12.39%
11.74%
11.25%
12.79%
12.61%
Gross Profit Margin
14.18%
14.35%
13.53%
12.39%
8.15%
12.6%
PAT Margin
8.03%
9.22%
8.31%
8.18%
3.64%
4.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 20.43% vs 22.97% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 4.81% vs 36.50% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 20.39% vs 29.81% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 294.59% vs 40.51% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Windlas Biotech With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
759.88
0
759.88
Other Operating Income
0.00
0.00
0.00
Total Operating income
759.88
0
759.88
Raw Material Cost
493.38
0
493.38
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-21.52
0
-21.52
Employee Cost
122.92
0
122.92
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
70.99
0.00
70.99
Total Expenditure (Excl Depreciation)
665.77
0
665.77
Operating Profit (PBDIT) excl Other Income
94.11
0.00
94.11
Other Income
18.02
0
18.02
Operating Profit (PBDIT)
112.13
0
112.13
Interest
4.38
0
4.38
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
107.75
0
107.75
Depreciation
27.99
0
27.99
Profit Before Tax
79.76
0
79.76
Tax
18.76
0
18.76
Provisions and contingencies
0.00
0
0.00
Profit After Tax
60.99
0
60.99
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
60.99
0
60.99
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
60.99
0
60.99
Equity Capital
10.48
0
10.48
Face Value
5.00
0
0.00
Reserves
495.29
0
495.29
Earnings per share (EPS)
29.10
0
29.10
Diluted Earnings per share
28.87
0
28.87
Operating Profit Margin (Excl OI)
12.38%
0%
0.00
12.38%
Gross Profit Margin
14.18%
0%
0.00
14.18%
PAT Margin
8.03%
0%
0.00
8.03%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 759.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.43% vs 22.97% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 60.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.81% vs 36.50% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.11 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.39% vs 29.81% in Mar 2024
Annual - Interest
Interest 4.38 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 294.59% vs 40.51% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.38%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
